BILLERICA, Massachusetts – February 02, 2022 – In a major breakthrough in Long COVID research the University of Cambridge (UK) and the Australian National Phenome Center (ANPC) have been using Bruker’s 600 MHz Avance III HD NMR spectrometer (IVDr)* to gain new insights into the risk and progression of Long COVID. Recently published research1 in Nature Immunology reveals distinct systemic recovery profiles over several months after infection with SARS-CoV-2. The paper also presents a new online predictive model that can determine the likelihood of individual patient disease courses and recovery.
For more information regarding the publication, refer to the press release by Murdoch University in Perth, Australia: https://www.murdoch.edu.au/news/articles/this-research-model-predicts-who-will-fully-recover-from-covid-19
For more information regarding Bruker Avance, visit: https://www.bruker.com/en/products-and-solutions/mr/nmr-clinical-research-solutions/avance-ivdr.html
*Bruker NMR instruments are for research use only and not intended for use in clinical diagnostic procedures
Prof. Jeremy Nicholson, Pro-Vice Chancellor for Health Services at Murdoch University, Perth, Australia, and Fellow of the UK Academy of Medical Science
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high performance scientific instruments and high value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular and cell biology research, in applied and pharma applications, in microscopy and nanoanalysis, as well as in industrial applications. Bruker offers differentiated, high-value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. For more information, please visit: www.bruker.com.